[HTML][HTML] Recent advances in polysaccharides based biomaterials for drug delivery and tissue engineering applications

A Sood, A Gupta, G Agrawal - Carbohydrate Polymer Technologies and …, 2021 - Elsevier
In this paper, a spotlight is shown on polysaccharides based biomaterials which have
surfaced as a versatile platform for different biomedical applications including drug delivery …

Advances in development of new treatment for leishmaniasis

JPB de Menezes, CES Guedes… - BioMed research …, 2015 - Wiley Online Library
Leishmaniasis is a neglected infectious disease caused by several different species of
protozoan parasites of the genus Leishmania. Current strategies to control this disease are …

[HTML][HTML] Polymeric nanoparticles of Brazilian red propolis extract: preparation, characterization, antioxidant and leishmanicidal activity

TG Do Nascimento, PF Da Silva, LF Azevedo… - Nanoscale research …, 2016 - Springer
The ever-increasing demand for natural products and biotechnology derived from bees and
ultra-modernization of various analytical devices has facilitated the rational and planned …

[HTML][HTML] Nanotechnology based solutions for anti-leishmanial impediments: a detailed insight

H Jamshaid, FU Din, GM Khan - Journal of Nanobiotechnology, 2021 - Springer
As a neglected tropical disease, Leishmaniasis is significantly instigating morbidity and
mortality across the globe. Its clinical spectrum varies from ulcerative cutaneous lesions to …

Giardiasis: characteristics, pathogenesis and new insights about treatment

V Vivancos, I González-Alvarez… - Current topics in …, 2018 - ingentaconnect.com
Giardia intestinalis infection causes enterocytes damage and loss of brush border of the
epithelial cells of the intestine that leads to shortening of microvilli and altered epithelial …

[HTML][HTML] Current status of nanoscale drug delivery and the future of nano-vaccine development for leishmaniasis–A review

P Prasanna, P Kumar, S Kumar, VK Rajana… - Biomedicine & …, 2021 - Elsevier
The study of tropical diseases like leishmaniasis, a parasitic disease, has not received much
attention even though it is the second-largest infectious disease after malaria. As per the …

Extracellular matrix component-derived nanoparticles for drug delivery and tissue engineering

KJ Hogan, MR Perez, AG Mikos - Journal of Controlled Release, 2023 - Elsevier
The extracellular matrix (ECM) consists of a complex combination of proteins, proteoglycans,
and other biomolecules. ECM-based materials have been demonstrated to have high …

Nanostructured delivery systems with improved leishmanicidal activity: a critical review

N Bruni, B Stella, L Giraudo, C Della Pepa… - International journal …, 2017 - Taylor & Francis
Leishmaniasis is a vector-borne zoonotic disease caused by protozoan parasites of the
genus Leishmania, which are responsible for numerous clinical manifestations, such as …

Recent advances in amphotericin B delivery strategies for the treatment of leishmaniases

JS Lanza, S Pomel, PM Loiseau… - Expert opinion on drug …, 2019 - Taylor & Francis
Introduction: Among the drugs in clinical use for the treatment of leishmaniases,
amphotericin B (AmB) is the most effective and has been the most extensively studied for the …

[HTML][HTML] Activity of amphotericin B-loaded chitosan nanoparticles against experimental cutaneous leishmaniasis

A Riezk, K Van Bocxlaer, V Yardley, S Murdan, SL Croft - Molecules, 2020 - mdpi.com
Chitosan nanoparticles have gained attention as drug delivery systems (DDS) in the medical
field as they are both biodegradable and biocompatible with reported antimicrobial and anti …